Inborn Errors of Metabolism

1. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

• Diagnosis: Medium-Chain Acyl-CoA Dehydrogenase Deficiency
• Cause: Deficiency in the MCAD enzyme, needed to break down medium-chain fatty acids for energy production. Autosomal recessive inheritance.
• Most Common Scenario: Presents in infancy or early childhood, often triggered by illness or prolonged fasting.
• Physical Exam Findings:
• May be normal between episodes.
• During acute episodes: Lethargy, vomiting, hypotonia, seizures, hepatomegaly.
• Lab Abnormalities:
• Hypoketotic hypoglycemia (low glucose, inappropriately low ketones).
• Elevated plasma acylcarnitines (especially C8 and C8:1).
• Elevated liver transaminases (AST, ALT).
• Dicarboxylic aciduria (in urine).
• Differentiating Features: Hypoketotic hypoglycemia. Acylcarnitine profile showing elevated C8 and C8:1 is diagnostic .
• Recommended Dietary Changes:
• Frequent feedings: Avoid prolonged fasting. Small, frequent meals and snacks.
• Avoidance of medium-chain triglycerides (MCTs): These are the fats they cannot process. Note: Regular infant formula does NOT use MCT oil, so this isn't really an issue for infants .
• High-carbohydrate diet: Provide readily available glucose to prevent fat breakdown.
• Emergency protocol: During illness, provide IV glucose and carnitine supplementation (Not universally required. It’s used selectively based on plasma carnitine levels and clinical context.).

2. Maple Syrup Urine Disease (MSUD)

• Diagnosis: Maple Syrup Urine Disease
• Cause: Deficiency in branched-chain alpha-keto acid dehydrogenase (BCKDH) complex, needed to break down leucine, isoleucine, and valine - results in branched chain amino acids and corresponding ketoacids building up in the blood. Autosomal recessive inheritance.
• Most Common Scenario: Presents in the first few days of life.
• Physical Exam Findings:
• Lethargy, poor feeding, irritability.vomiting in the newborn period
• Progressive encephalopathy
  
• Maple syrup odor in urine, cerumen (earwax), and sweat. "sweet smelling"
  
• Alternating hypertonia and hypotonia.
• Seizures, coma.
• Lab Abnormalities:
• Elevated plasma levels of leucine, isoleucine, and valine. Alloisoleucine is a pathognomonic marker.
• Elevated plasma and urine levels of Leucine are a hallmark of MSUD
  
• Ketonuria.
• Hypoglycemia may be present - not defining or consistent in MSUD.
• Differentiating Features: Maple syrup odor . Elevated branched-chain amino acids are diagnostic .
• Early Diagnosis and dietary management can prevent intellectual disability and death
  
• Recommended Dietary Changes:
• Strict restriction of leucine, isoleucine, and valine: Lifelong dietary management.
• Specialized formula: MSUD-specific formula that is free of branched-chain amino acids.
• Carefully measured amounts of regular formula or breast milk: To provide the minimum necessary amount of branched-chain amino acids for growth.
• Frequent monitoring of branched-chain amino acid levels: To adjust the diet.
• Emergency protocol: During illness, may need to increase leucine-free formula and decrease natural protein. Dialysis in extreme cases to rapidly reduce leucine levels
  
• Summary:
  
• Maple Syrup Urine Disease (MSUD) is an autosomal recessive inborn error of branched-chain amino acid metabolism due to deficiency of the branched-chain α-ketoacid dehydrogenase complex. It leads to accumulation of leucine, isoleucine, and valine in plasma and urine, causing progressive neurologic dysfunction, encephalopathy, and potentially neonatal death if untreated. Early symptoms include poor feeding, vomiting, lethargy, and a characteristic sweet-smelling urine. Prompt diagnosis and dietary management are critical to prevent long-term complications such as intellectual disability.

3. Phenylketonuria (PKU)

• Diagnosis: Phenylketonuria
• Cause: Deficiency in phenylalanine hydroxylase (PAH), needed to convert phenylalanine to tyrosine. Autosomal recessive inheritance.
• Most Common Scenario: Typically detected on newborn screening. If untreated, symptoms develop over time.
• Physical Exam Findings:
• Often normal at birth.
• If untreated: Fair skin and hair, eczema, musty odor.
• Later: Intellectual disability, seizures. These are NOT presenting features in the newborn period .
• Lab Abnormalities:
• Elevated phenylalanine levels in plasma.
• Normal urine ketones initially.
• Differentiating Features: Elevated phenylalanine levels. Most asymptomatic in the first few days.
• Recommended Dietary Changes:
• Restriction of phenylalanine: Lifelong dietary management.
• Tyrosine supplementation (conditionally essential in PKU)
  
• Specialized formula: Phenylalanine-free formula.
• Limited amounts of regular formula or breast milk: To provide the necessary phenylalanine for growth.
• Avoidance of high-protein foods: Meat, fish, poultry, eggs, dairy, nuts, and legumes.
• Frequent monitoring of phenylalanine levels: To adjust the diet.

4. Homocystinuria

• Diagnosis: Homocystinuria
• Cause: Most commonly, deficiency in cystathionine beta-synthase (CBS), involved in methionine metabolism. Autosomal recessive inheritance.
• Most Common Scenario: Variable presentation. Some cases detected on newborn screening, others diagnosed later.
• Physical Exam Findings:
• Often asymptomatic in newborns.
• Later findings (not usually present in newborns): Dislocated lenses (ectopia lentis), skeletal abnormalities (long limbs, scoliosis), intellectual disability, thromboembolic events.
• Lab Abnormalities:
• Elevated homocysteine levels in plasma and urine.
• Elevated methionine levels in plasma.
• Differentiating Features: Elevated homocysteine and methionine. Later presentation is typical.
• Recommended Dietary Changes:
• Restriction of methionine: Lifelong dietary management.
• Specialized formula: Methionine-free or low-methionine formula.
• Carefully measured amounts of regular formula or breast milk: To provide minimum methionine needs.
• Supplementation: Some patients benefit from supplementation with betaine (trimethylglycine) and vitamin B6 (pyridoxine). Folate and vitamin B12 may also be used depending on responsiveness.

5. Tyrosinemia Type 1

• Diagnosis: Tyrosinemia Type 1
• Cause: Deficiency in fumarylacetoacetate hydrolase (FAH), the last enzyme in the tyrosine degradation pathway. Autosomal recessive inheritance.
• Most Common Scenario: Variable presentation, ranging from acute liver failure in infancy to chronic liver disease.
• Physical Exam Findings:
• Hepatomegaly.
• Jaundice.
• Cabbage-like odor.
• Edema, ascites (fluid accumulation).
• Lab Abnormalities:
• Elevated tyrosine levels in plasma.
• Elevated succinylacetone in urine (highly specific).
• Liver function abnormalities (elevated AST, ALT, bilirubin).
• Prolonged PT/INR.
• Differentiating Features: Hepatomegaly, liver failure, succinylacetone in urine .
• Recommended Dietary Changes:
• Restriction of phenylalanine and tyrosine: Lifelong dietary management.
• Routine monitoring of plasma tyrosine and phenylalanine levels to avoid neurotoxicity from excess tyrosine
  
• Specialized formula: Phenylalanine- and tyrosine-free formula.
• Limited amounts of regular formula or breast milk: To provide minimum amounts needed.
• Nitisinone (Orfadin): This medication inhibits an enzyme upstream in the tyrosine pathway, preventing the buildup of toxic metabolites. This medication has dramatically improved outcomes and is now a mainstay of treatment.

6. Urea Cycle Defects (UCDs) (General)

• Diagnosis: Urea Cycle Defect (e.g., Ornithine Transcarbamylase Deficiency - OTC)
• Cause: Deficiency in one of the enzymes involved in the urea cycle, which removes ammonia from the blood. Most are autosomal recessive, except OTC deficiency, which is X-linked.
• Most Common Scenario: Presents in the first few days of life with rapidly progressive hyperammonemia.
• Physical Exam Findings:
• Progressive lethargy, poor feeding, vomiting.
• Seizures, coma.
• Respiratory distress.
• Lab Abnormalities:
• Markedly elevated ammonia levels in the blood.
• Respiratory alkalosis - secondary to hyperventilation from cerebral edema
  
• Variable amino acid profiles, depending on the specific UCD.
• Differentiating Features: Markedly elevated ammonia level . Clinical deterioration despite supportive care.
• Recommended Dietary Changes:
• Protein restriction: Crucial to reduce ammonia production. The degree of restriction depends on the severity of the defect.
• Specialized formula: Low-protein formula with essential amino acids.
• Arginine supplementation: Especially important in defects distal to argininosuccinate (e.g., ASL deficiency)
• Medications: Sodium benzoate and sodium phenylbutyrate can help remove ammonia
• newer agents like glycerol phenylbutyrate (ravicti) may be used in chronic management
  
• Dietary management is VERY complex and individualized and requires expert guidance

Important Notes Regarding Dietary Management:

• Lifelong Commitment: Dietary management of IEMs is typically a lifelong commitment.
• Expert Guidance: These diets are complex and require close monitoring by a metabolic specialist and a registered dietitian with expertise in IEMs.
• Growth and Development: Ensuring adequate growth and development while restricting specific nutrients is a major challenge.
• Emergency Plans: Families need to have emergency plans in place for times of illness, as metabolic decompensation can occur rapidly.
• Adherence Challenges: Dietary adherence can be challenging, especially as children get older. Support from family, friends, and healthcare providers is crucial.

Key Differentiating Features (Summary Table):